The 2017 international classification replaces previous terms for symptomatic joint hypermobility. Ehlers-Danlos syndrome (EDS) and hypermobility spectrum disorder (HSD) are clinical diagnoses. The primary therapeutic goals are to alleviate the symptoms, prevent joint injuries and provide the best possible education for those affected.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- Neurology
Expecting the unexpected – a look into the future of diagnostics and therapy
- Compression
Lymphoedema and chronic wounds
- Epilepsy
The treatment of refractory status epilepticus – an overview
- Podiatry support to improve quality of life
Patient mobility with a foot wound
- Rare diseases
Cogan syndrome – a clinical challenge
- Polymyalgia rheumatica and giant cell arteritis
New consensus paper recommends “treat-to-target” strategy
- Threat from Aedes mosquitoes
Dengue, Zika and Chikungunya viruses on the rise
- Systemic lupus erythematosus